Key result
Cardiometabolic risk factors were highly prevalent among older adults, with age- and sex-standardized prevalences of 74.9% for hypertension, 49.7% for high cholesterol, 12.8% for obesity, and 9.5% for diabetes.
Cross-Sectional (n=3,363)
Cardiometabolic risk factors are highly prevalent among older adults in Sweden, and a significant proportion of those receiving pharmacological treatment do not reach therapeutic goals, highlighting a need for improved management.
May prompt closer monitoring of cardiometabolic risks in older adults; leaves open optimal management strategies.
BACKGROUND: Cardiometabolic risk factors and related cardiovascular diseases represent major threats to healthy aging. OBJECTIVE: We aimed to estimate distribution, pharmacological treatment, and control of main cardiometabolic risk factors among older people. METHODS: This population-based study included 3363 participants (age≥60 years, 64.9% women) in the Swedish National study on Aging and Care in Kungsholmen, in central Stockholm, Sweden (2001-2004). Data on demographics, cardiometabolic risk factors (hypertension, obesity, diabetes, and high cholesterol), and medication use were collected through face-to-face interviews, clinical examinations, laboratory tests, and the inpatient register. Cardiometabolic risk factors were defined following the most commonly used criteria. Prevalence was standardized using local census data. RESULTS: The age- and sex-standardized prevalence of diabetes, obesity, high cholesterol, and hypertension was 9.5%, 12.8%, 49.7%, and 74.9%, respectively. The prevalence of hypertension and diabetes increased with age, whereas the prevalence of obesity and high cholesterol decreased with age. Forty-nine percent of older adults had two or more cardiometabolic risk factors; 9.8% had three or more. Overall, 55.5% of people with hypertension, 50.3% with diabetes, and 25.0% with high cholesterol received pharmacological treatment. Of those treated pharmacologically, 49.4%, 38.1%, and 85.5% reached therapeutic goals for hypertension (blood pressure<150/90 mmHg), diabetes (glycated haemoglobin<7%), and high cholesterol (total cholesterol<6.22 mmol/l), respectively. CONCLUSIONS: Hypertension, high cholesterol, and clustering of cardiometabolic risk factors were common among older people in Stockholm, but pharmacological treatment and control of these major factors can be improved. Appropriate management of cardiometabolic profiles among older people may help improve cardiovascular health and achieve healthy aging.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2015) conducted a cross-sectional in Cardiometabolic risk factors (n=3,363). Cardiometabolic risk factors was evaluated on Prevalence of cardiometabolic risk factors (hypertension, high cholesterol, obesity, diabetes). Cardiometabolic risk factors were highly prevalent among older adults, with age- and sex-standardized prevalences of 74.9% for hypertension, 49.7% for high cholesterol, 12.8% for obesity, and 9.5% for diabetes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: